Tower Research Capital LLC (TRC) - LARIMAR THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,514
-52.6%
4,687
-62.4%
0.00%0.0%
Q2 2023$39,019
+650216.7%
12,466
+809.3%
0.00%
Q1 2023$6
-100.0%
1,371
-88.4%
0.00%
-100.0%
Q3 2022$38,000
+1800.0%
11,822
+836.8%
0.00%
Q2 2022$2,000
-60.0%
1,262
+3.9%
0.00%
Q1 2022$5,000
-58.3%
1,215
+7.9%
0.00%
Q4 2021$12,000
-82.1%
1,126
-80.7%
0.00%
-100.0%
Q3 2021$67,000
+415.4%
5,843
+334.4%
0.00%
Q2 2021$13,000
+30.0%
1,345
+89.4%
0.00%
Q1 2021$10,000
-75.6%
710
-63.3%
0.00%
-100.0%
Q4 2020$41,000
-30.5%
1,935
-50.2%
0.00%0.0%
Q3 2020$59,000
+195.0%
3,883
+148.1%
0.00%0.0%
Q2 2020$20,0001,5650.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
CHI Advisors LLC 3,473,366$14,345,0013.82%
Opaleye Management Inc. 1,560,000$6,442,8002.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,941,357$69,967,8041.45%
GREAT POINT PARTNERS LLC 1,273,635$5,260,1131.03%
DAFNA Capital Management LLC 473,136$1,954,0520.55%
COMMODORE CAPITAL LP 750,000$3,0980.47%
Cheyne Capital Management (UK) LLP 63,680$262,9980.46%
Atlas Venture Advisors, Inc. 292,184$1,206,7200.42%
Perceptive Advisors 2,860,000$11,811,8000.33%
MANGROVE PARTNERS IM, LLC 1,292,812$5,339,3140.30%
View complete list of LARIMAR THERAPEUTICS INC shareholders